Fighting type 2 diabetes: Formulation strategies for peptide-based therapeutics
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fighting type 2 diabetes: Formulation strategies for peptide-based therapeutics
Authors
Keywords
Type 2 diabetes mellitus, Glucagon-like peptide-1 receptor agonists, Exenatide, Subcutaneous administration, Amylin mimetics, Drug delivery systems, Biotherapeutics, Peptide delivery, Controlled-release formulations, Microparticles, Nanoparticles
Journal
Acta Pharmaceutica Sinica B
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-08-10
DOI
10.1016/j.apsb.2021.08.003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Semi-solid extrusion 3D printing in drug delivery and biomedicine: Personalised solutions for healthcare challenges
- (2021) Iria Seoane-Viaño et al. JOURNAL OF CONTROLLED RELEASE
- Translating 3D printed pharmaceuticals: From hype to real-world clinical applications
- (2021) Iria Seoane-Viaño et al. ADVANCED DRUG DELIVERY REVIEWS
- Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady‐state concentrations
- (2020) Karen L. Jones et al. DIABETES OBESITY & METABOLISM
- Accelerating the development of novel technologies and tools for the subcutaneous delivery of biotherapeutics
- (2020) DavidS. Collins et al. JOURNAL OF CONTROLLED RELEASE
- Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial
- (2020) Christopher K. Rayner et al. DIABETES CARE
- Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice
- (2020) Xiaoyan Bao et al. JOURNAL OF NANOBIOTECHNOLOGY
- Exenatide Once Weekly: Effectiveness, Tolerability, and Discontinuation Predictors in a Real-World Setting
- (2020) Giulia Di Dalmazi et al. CLINICAL THERAPEUTICS
- Drug-encapsulated blend of PLGA-PEG microspheres: in vitro and in vivo study of the effects of localized/targeted drug delivery on the treatment of triple-negative breast cancer
- (2020) S. M. Jusu et al. Scientific Reports
- Assisted 3D printing of microneedle patches for minimally invasive glucose control in diabetes
- (2020) Mingxin Wu et al. Materials Science & Engineering C-Materials for Biological Applications
- Formation Mechanism, In vitro and In vivo Evaluation of Dimpled Exenatide Loaded PLGA Microparticles Prepared by Ultra-Fine Particle Processing System
- (2019) Chune Zhu et al. AAPS PHARMSCITECH
- Subcutaneous delivery of biotherapeutics: challenges at the injection site
- (2019) Joana A. D. Sequeira et al. Expert Opinion on Drug Delivery
- Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
- (2019) A. Arranz-Romera et al. JOURNAL OF CONTROLLED RELEASE
- Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption
- (2019) Yina Song et al. MOLECULAR PHARMACEUTICS
- Sustained Release of Exendin 4 Using Injectable and Ionic-Nano-Complex Forming Polymer Hydrogel System for Long-Term Treatment of Type 2 Diabetes Mellitus
- (2019) Bo-Bae Seo et al. ACS Applied Materials & Interfaces
- Sustained release of exendin-4 from tannic acid/Fe (III) nanoparticles prolongs blood glycemic control in a mouse model of type II diabetes
- (2019) Zhiyu He et al. JOURNAL OF CONTROLLED RELEASE
- Synthesis and Statistical Optimization of Poly (Lactic-Co-Glycolic Acid) Nanoparticles Encapsulating GLP1 Analog Designed for Oral Delivery
- (2019) Ruba Ismail et al. PHARMACEUTICAL RESEARCH
- Development of composite PLGA microspheres containing exenatide-encapsulated lecithin nanoparticles for sustained drug release
- (2019) Ni Dong et al. Asian Journal of Pharmaceutical Sciences
- Glucagon-Like Peptide-1 Receptor Analogues in Type 2 Diabetes: Their Use and Differential Features
- (2019) Katherine A. Lyseng-Williamson CLINICAL DRUG INVESTIGATION
- A once-monthly GLP-1 receptor agonist for treatment of diabetic cats
- (2019) E.L. Schneider et al. DOMESTIC ANIMAL ENDOCRINOLOGY
- Novel strategy for oral peptide delivery in incretin-based diabetes treatment
- (2019) Yining Xu et al. GUT
- Preparation and evaluation of lactic acid acylated exenatide and its long-acting preparation
- (2019) Aiping Wang et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Rationally Designed Dendritic Silica Nanoparticles for Oral Delivery of Exenatide
- (2019) Muhammad Mustafa Abeer et al. Pharmaceutics
- Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site
- (2019) Iris Usach et al. ADVANCES IN THERAPY
- Sustained release and pharmacologic evaluation of human glucagon-like peptide-1 and liraglutide from polymeric microparticles
- (2019) Luis Peña Icart et al. JOURNAL OF MICROENCAPSULATION
- Effect of Stabilizers on Encapsulation Efficiency and Release Behavior of Exenatide-Loaded PLGA Microsphere Prepared by the W/O/W Solvent Evaporation Method
- (2019) Heejun Park et al. Pharmaceutics
- Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability
- (2019) Nicholas G. Lamson et al. Nature Biomedical Engineering
- A polyphenol-metal nanoparticle platform for tunable release of liraglutide to improve blood glycemic control and reduce cardiovascular complications in a mouse model of type II diabetes
- (2019) Zhiyu He et al. JOURNAL OF CONTROLLED RELEASE
- Coating of PLA-nanoparticles with cyclic, arginine-rich cell penetrating peptides enables oral delivery of liraglutide
- (2019) P. Uhl et al. Nanomedicine-Nanotechnology Biology and Medicine
- Battle of GLP-1 delivery technologies
- (2018) Minzhi Yu et al. ADVANCED DRUG DELIVERY REVIEWS
- Effects of the multilayer structures on Exenatide release and bioactivity in microsphere/thermosensitive hydrogel system
- (2018) Puxiu Wang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- In vitro models for immunogenicity prediction of therapeutic proteins
- (2018) Floriane Groell et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Nanoparticles induced by embedding self-assembling cassette into glucagon-like peptide 1 for improving in vivo stability
- (2018) Ying Li et al. FASEB JOURNAL
- 3D printed microneedles for insulin skin delivery
- (2018) Cristiane Patricia Pissinato Pere et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The use of low molecular weight protamine to enhance oral absorption of exenatide
- (2018) Liping Zhang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- In vitro model for predicting bioavailability of subcutaneously injected monoclonal antibodies
- (2018) Hanne Kinnunen Bown et al. JOURNAL OF CONTROLLED RELEASE
- In vivo evaluation of an oral self-emulsifying drug delivery system (SEDDS) for exenatide
- (2018) Claudia Menzel et al. JOURNAL OF CONTROLLED RELEASE
- Challenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins
- (2018) Michael R. Turner et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Long-Acting Release Microspheres Containing Novel GLP-1 Analog as an Antidiabetic System
- (2018) Sida Ruan et al. MOLECULAR PHARMACEUTICS
- Thymoquinone loaded in nanostructured lipid carrier showed enhanced anticancer activity in 4T1 tumor-bearing mice
- (2018) Yong Sze Ong et al. Nanomedicine
- Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease
- (2018) Dilan Athauda et al. NEUROPHARMACOLOGY
- Immunogenicity of pulsatile-release PLGA microspheres for single-injection vaccination
- (2018) Rohiverth Guarecuco et al. VACCINE
- Fc-modified exenatide-loaded nanoparticles for oral delivery to improve hypoglycemic effects in mice
- (2018) Yanan Shi et al. Scientific Reports
- Exendin-4–encapsulated dissolving microneedle arrays for efficient treatment of type 2 diabetes
- (2018) Shayan Fakhraei Lahiji et al. Scientific Reports
- Amylin – Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity
- (2018) Christina Neuner Boyle et al. Molecular Metabolism
- Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities
- (2018) Beate Bittner et al. BIODRUGS
- Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?
- (2018) Raffaella Gentilella et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Development of chitosan coated calcium-alginate nanocapsules for oral delivery of liraglutide to diabetic patients
- (2018) Fatemeh Shamekhi et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Subcutaneous delivery of monoclonal antibodies: How do we get there?
- (2018) Margarida Viola et al. JOURNAL OF CONTROLLED RELEASE
- Hollow Microparticles as a Superior Delivery System over Solid Microparticles for the Encapsulation of Peptides
- (2018) Sharad Kharel et al. PHARMACEUTICAL RESEARCH
- Glucagon-like peptide-1 receptor agonists for type 2 diabetes: A rational drug development
- (2018) Bo Ahrén Journal of Diabetes Investigation
- Pharmacodynamical effects of orally administered exenatide nanoparticles embedded in gastro-resistant microparticles
- (2018) Liat Soudry-Kochavi et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Chitosan-based thermosensitive hydrogel for nasal delivery of exenatide: Effect of magnesium chloride
- (2018) Ying Li et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Long-term oral administration of Exendin-4 to control type 2 diabetes in a rat model
- (2018) Kenichi Suzuki et al. JOURNAL OF CONTROLLED RELEASE
- Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction
- (2018) Noriyasu Kamei et al. Scientific Reports
- The Discovery of Insulin: An Important Milestone in the History of Medicine
- (2018) Ignazio Vecchio et al. Frontiers in Endocrinology
- A Comprehensive Map of FDA-Approved Pharmaceutical Products
- (2018) Hao Zhong et al. Pharmaceutics
- Preparation of exenatide-loaded linear poly(ethylene glycol)-brush poly(L-lysine) block copolymer: potential implications on diabetic nephropathy
- (2017) Fei Tong International Journal of Nanomedicine
- Exenatide-loaded microsphere/thermosensitive hydrogel long-acting delivery system with high drug bioactivity
- (2017) Puxiu Wang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Current and future pharmacological therapies for NAFLD/NASH
- (2017) Yoshio Sumida et al. JOURNAL OF GASTROENTEROLOGY
- Microneedle-array patches loaded with dual mineralized protein/peptide particles for type 2 diabetes therapy
- (2017) Wei Chen et al. Nature Communications
- Sustained-release study on Exenatide loaded into mesoporous silica nanoparticles: in vitro characterization and in vivo evaluation
- (2017) Cuiwei Chen et al. DARU-Journal of Pharmaceutical Sciences
- The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers
- (2017) Neha Shrestha et al. Nanoscale
- Hydrogel Drug Delivery System Using Self-Cleaving Covalent Linkers for Once-a-Week Administration of Exenatide
- (2016) Eric L. Schneider et al. BIOCONJUGATE CHEMISTRY
- Glycosaminoglycans contribute to extracellular matrix fiber recruitment and arterial wall mechanics
- (2016) Jeffrey M. Mattson et al. Biomechanics and Modeling in Mechanobiology
- Liraglutide Versus Exenatide Once Weekly: Persistence, Adherence, and Early Discontinuation
- (2016) Maria Yu et al. CLINICAL THERAPEUTICS
- Understanding Subcutaneous Tissue Pressure for Engineering Injection Devices for Large-Volume Protein Delivery
- (2016) Diane V. Doughty et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Subcutaneous Injection Volume of Biopharmaceuticals—Pushing the Boundaries
- (2016) Roman Mathaes et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Comparative studies on exenatide-loaded poly ( d , l -lactic-co-glycolic acid) microparticles prepared by a novel ultra-fine particle processing system and spray drying
- (2015) Chune Zhu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- GLP-1 and Amylin in the Treatment of Obesity
- (2015) T. Jorsal et al. Current Diabetes Reports
- Breaching the skin barrier through temperature modulations
- (2015) Yasser Shahzad et al. JOURNAL OF CONTROLLED RELEASE
- A novel in vitro method to model the fate of subcutaneously administered biopharmaceuticals and associated formulation components
- (2015) Hanne M. Kinnunen et al. JOURNAL OF CONTROLLED RELEASE
- Exploratory Trial of Intranasal Administration of Glucagon-Like Peptide-1 in Japanese Patients With Type 2 Diabetes: Figure 1
- (2014) Hiroaki Ueno et al. DIABETES CARE
- Intranasal delivery of systemic-acting drugs: Small-molecules and biomacromolecules
- (2014) Ana Fortuna et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Subcutaneous Administration of Monoclonal Antibodies in Oncology
- (2014) C. Jackisch et al. GEBURTSHILFE UND FRAUENHEILKUNDE
- Improving the outcomes of biopharmaceutical delivery via the subcutaneous route by understanding the chemical, physical and physiological properties of the subcutaneous injection site
- (2014) Hanne M. Kinnunen et al. JOURNAL OF CONTROLLED RELEASE
- Rapidly Dissolvable Microneedle Patches for Transdermal Delivery of Exenatide
- (2014) Zhuangzhi Zhu et al. PHARMACEUTICAL RESEARCH
- Enhancing the Buccal Mucosal Delivery of Peptide and Protein Therapeutics
- (2014) Thiago Caon et al. PHARMACEUTICAL RESEARCH
- Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European Countries
- (2014) Victoria Divino et al. Diabetes Therapy
- Preparation of uniform-sized exenatide-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency and bio-stability
- (2013) Feng Qi et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Do current incretin mimetics exploit the full therapeutic potential inherent in GLP-1 receptor stimulation?
- (2013) M. A. Nauck et al. DIABETOLOGIA
- Immunogenicity of therapeutic proteins: Influence of aggregation
- (2013) Kirsty D. Ratanji et al. Journal of Immunotoxicology
- Exenatide-loaded PLGA microspheres with improved glycemic control: In vitro bioactivity and in vivo pharmacokinetic profiles after subcutaneous administration to SD rats
- (2013) Jiming Xuan et al. PEPTIDES
- Mechanistic Determinants of Biotherapeutics Absorption Following SC Administration
- (2012) Wolfgang F. Richter et al. AAPS Journal
- Microneedles for drug and vaccine delivery
- (2012) Yeu-Chun Kim et al. ADVANCED DRUG DELIVERY REVIEWS
- Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment
- (2012) M. S. Fineman et al. DIABETES OBESITY & METABOLISM
- Nasal drug delivery — Recent developments and future prospects
- (2012) Lisbeth Illum JOURNAL OF CONTROLLED RELEASE
- High efficiency intranasal drug delivery using Intravail® alkylsaccharide absorption enhancers
- (2012) Edward T. Maggio et al. Drug Delivery and Translational Research
- Encapsulation of Exenatide in Poly-(d,l-Lactide-Co-Glycolide) Microspheres Produced an Investigational Long-Acting Once-Weekly Formulation for Type 2 Diabetes
- (2011) Mary Beth DeYoung et al. Diabetes Technology & Therapeutics
- Pharmacokinetics and Pharmacodynamics of Inhaled GLP-1 (MKC253): Proof-of-Concept Studies in Healthy Normal Volunteers and in Patients With Type 2 Diabetes
- (2010) M T Marino et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Liposomal formulations of glucagon-like peptide-1: Improved bioavailability and anti-diabetic effect
- (2009) Junko Hanato et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- How Changes in the Sequence of the Peptide CLPFFD-NH2Can Modify the Conjugation and Stability of Gold Nanoparticles and Their Affinity for β-Amyloid Fibrils
- (2008) Ivonne Olmedo et al. BIOCONJUGATE CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation